Should the left main be covered entirely with drug-eluting stents in percutaneous intervention.
Restenosis after percutaneous intervention in the left main coronary artery may present as sudden cardiac death. Although drug-eluting stents have demonstrated promising results, there remains the question about appropriate length of the left main artery to be covered with the stent. We describe a patient who received two drug-eluting stents with the balloon crushing technique in the distal left main coronary artery. Three months later, this patient presented with a new lesion in the segment of the left main artery not covered with stent, but instead at the site where the balloon was inflated in the initial procedure.
Lozano
Iñigo
I
Department of Cardiology, Hospital Central Asturias, Celestino Villamil, Oviedo, 33006, Spain. imlml9@hotmail.com
Avanzas
Pablo
P
Moris
Cesar
C
D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation* / Q000379:methods; D006328:Cardiac Catheterization / Q000379:methods; D017023:Coronary Angiography / Q000379:methods; D001026:Coronary Artery Bypass / Q000009:adverse effects* / Q000379:methods; D023903:Coronary Restenosis / Q000000981:diagnostic imaging / Q000209:etiology / Q000517:prevention & control*; D023921:Coronary Stenosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery*; D003331:Coronary Vessels; D016503:Drug Delivery Systems / Q000379:methods*; D005260:Female; D006801:Humans; D008875:Middle Aged; D019233:Retreatment; D018570:Risk Assessment; D012720:Severity of Illness Index; D020123:Sirolimus / Q000494:pharmacology; D015607:Stents; D016896:Treatment Outcome
D020123:Sirolimus